Built for Imaging Centers.
Trusted by Radiologists.

Nanox.AI’s FDA-cleared software products analyze existing CT scans for early disease markers —
without changing your current workflow or increasing scan time.

Real Clinical & Operational Impact

FOR RADIOLOGISTS

FOR RADIOLOGISTS

  • Detect incidental findings in addition to the original indication
  • Reduce variability and boost clinician confidence
  • Improve diagnostic output without added time conditions

FOR IMAGING CENTERS

FOR IMAGING CENTERS

  • Enhance the value of every CT scan
  • Differentiate your practice with cutting-edge AI
  • Create new follow-up pathways and downstream referrals
  • Strengthen referral partnerships

4 Indications, 1 CT Scan,
No Added Exposure

NANOX.AI DETECTS THE FOLLOWING CONDITIONS:

Coronary Artery Calcification (CAC)
Identify early cardiac risk
VCF detection
Aid in osteoporosis detection
BMD measured in HU
Contribute to fracture prevention
Liver attenuation out of range
Uncover metabolic disease

Nanox.AI solutions were selected for a Special Mention on TIME’s annual list, recognizing groundbreaking innovations
changing how we live

Diagnose Earlier. Report Sooner.
Enhance Patient Care.

YOU’RE ALREADY PERFORMING THE SCANS. NANOX.AI ENHANCES THEIR VALUE.

Join us on Nanox.AI’s journey to discover how our innovative technology can elevate your practice and drive
healthcare standards to new heights.

Works on existing
CT scans
Works on existing
CT scans
FDA-cleared for multiple
clin
FDA-cleared for multiple
clinical conditions
Seamless PACS or
cloud integr
Seamless PACS or
cloud integration
No disruption
to workflow
No disruption
to workflow
No additional
scan time
No additional
scan time
No OPEX/No CAPEX
No OPEX/No CAPEX

Field-Proven Value

DO MORE WITH AI SOLUTIONS

By using Nanox.AI’s cardiac solution, Corewell Health significantly increased their ability to detect coronary calcification, identifying nearly 4,000 new patients in 2023 compared to just 268 patients having CAC reported in the previous two years.

Dr. Langholz, M.D., FACC FASE
Dr. Langholz, M.D., FACC FASE

Frederick Meijer Heart and Vascular Institute
Spectrum Health, Grand Rapids, MI Clinical
Professor, MSU School of Medicine

Diagram
Prof. Kassim Javaid
Prof. Kassim Javaid
Professor of Osteoporosis & Adult Rare Bone Diseases

Al re-analysis of scans can catch missed fractures, as shown In the ADOPT Study across NHS locations. This innovation delivers proactive care for high fracture-risk patients who are otherwise missed

Devon Klein, MD MPH MBA CPE
Devon Klein, MD MPH MBA CPE
Atlantic Health

Utilizing Nanox.AI to detect incidental CAC in patients can lead to early intervention with primary prevention strategies which would ultimately improve long term outcome and decrease healthcare costs

Professor of Radiology and Med
Professor of Radiology and Medical Physics
University of Wisconsin-Madison

The ever-growing suite of opportunistic AI tools provided by Nanox.AI will allow for earlier detection of many important medical conditions such as osteoporosis, cardiovascular disease, and hepatic steatosis

Dr. Langholz, M.D., FACC FASE
Dr. Langholz, M.D., FACC FASE

The great thing about Nanox as a vendor is that it’s agnostic in terms of PAC systems and able to integrate seamlessly

Will Studholme
Will Studholme

I feel very lucky, I don’t think this would have been picked up without the AI technology.

Chana Gal Or
Chana Gal Or
Was diagnosed with heart condition by clinicians who used Nanox.Al Cardiac Solution

I had to come due to lung issues and along the way I was diagnosed with heart disease… maybe it was life saving

Differentiate Your Imaging Practice

Schedule your 20-minute strategy call and see how Nanox.AI can support early detection, improve outcomes, and help your outpatient radiology center thrive. Book directly through this link or fill out our form.

Your information will be handled as detailed in our Privacy Policy